219 related articles for article (PubMed ID: 26602013)
21. Copy number variants in clinical next-generation sequencing data can define the relationship between simultaneous tumors in an individual patient.
Sehn JK; Abel HJ; Duncavage EJ
Exp Mol Pathol; 2014 Aug; 97(1):69-73. PubMed ID: 24886963
[TBL] [Abstract][Full Text] [Related]
22. Performance Characteristics of a Targeted Sequencing Platform for Simultaneous Detection of Single Nucleotide Variants, Insertions/Deletions, Copy Number Alterations, and Gene Fusions in Cancer Genome.
Park K; Tran H; Eng KW; Ramazanoglu S; Marrero Rolon RM; Scognamiglio T; Borczuk A; Mosquera JM; Pan Q; Sboner A; Rubin MA; Elemento O; Rennert H; Fernandes H; Song W
Arch Pathol Lab Med; 2020 Dec; 144(12):1535-1546. PubMed ID: 32045275
[TBL] [Abstract][Full Text] [Related]
23. High-throughput detection of clinically targetable alterations using next-generation sequencing.
Vendrell JA; Grand D; Rouquette I; Costes V; Icher S; Selves J; Larrieux M; Barbe A; Brousset P; Solassol J
Oncotarget; 2017 Jun; 8(25):40345-40358. PubMed ID: 28404952
[TBL] [Abstract][Full Text] [Related]
24. Analytical and Clinical Validation of a Target-Enhanced Whole Genome Sequencing-Based Comprehensive Genomic Profiling Test.
Ferguson S; Sriram S; Wallace JK; Lee J; Kim JA; Lee Y; Oh BB; Lee WC; Lee S; Connolly-Strong E
Cancer Invest; 2024 May; 42(5):390-399. PubMed ID: 38773925
[TBL] [Abstract][Full Text] [Related]
25. Confirming Variants in Next-Generation Sequencing Panel Testing by Sanger Sequencing.
Baudhuin LM; Lagerstedt SA; Klee EW; Fadra N; Oglesbee D; Ferber MJ
J Mol Diagn; 2015 Jul; 17(4):456-61. PubMed ID: 25960255
[TBL] [Abstract][Full Text] [Related]
26. Detection of multiple types of cancer driver mutations using targeted RNA sequencing in non-small cell lung cancer.
Ju S; Cui Z; Hong Y; Wang X; Mu W; Xie Z; Zeng X; Su L; Lin X; Zhang Z; Zhang Q; Song X; You S; Chen R; Chen W; Xu C; Zhao J
Cancer; 2023 Aug; 129(15):2422-2430. PubMed ID: 37096747
[TBL] [Abstract][Full Text] [Related]
27. Bioinformatics Basics for High-Throughput Hybridization-Based Targeted DNA Sequencing from FFPE-Derived Tumor Specimens: From Reads to Variants.
Sun S; Murray SS
Methods Mol Biol; 2019; 1908():37-48. PubMed ID: 30649719
[TBL] [Abstract][Full Text] [Related]
28. Preparation of multiplexed control materials for cancer mutation analysis by genome editing in GM12878 cells.
Lin G; Zhang K; Han Y; Peng R; Li J
J Clin Lab Anal; 2022 Jan; 36(1):e24139. PubMed ID: 34811797
[TBL] [Abstract][Full Text] [Related]
29. Considerations of developing an NGS assay for clinical applications in precision oncology: The NCI-MATCH NGS assay experience.
Lih CJ; Takebe N
Curr Probl Cancer; 2017; 41(3):201-211. PubMed ID: 28625332
[TBL] [Abstract][Full Text] [Related]
30. Detection of BRCA1/2 large genomic rearrangement including BRCA1 promoter-region deletions using next-generation sequencing.
Han E; Yoo J; Chae H; Lee S; Kim DH; Kim KJ; Kim Y; Kim M
Clin Chim Acta; 2020 Jun; 505():49-54. PubMed ID: 32092317
[TBL] [Abstract][Full Text] [Related]
31. Validation of the Oncomine
Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
[TBL] [Abstract][Full Text] [Related]
32. Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants.
Pestinger V; Smith M; Sillo T; Findlay JM; Laes JF; Martin G; Middleton G; Taniere P; Beggs AD
Mol Diagn Ther; 2020 Jun; 24(3):339-349. PubMed ID: 32306292
[TBL] [Abstract][Full Text] [Related]
33. A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors.
Luthra R; Patel KP; Routbort MJ; Broaddus RR; Yau J; Simien C; Chen W; Hatfield DZ; Medeiros LJ; Singh RR
J Mol Diagn; 2017 Mar; 19(2):255-264. PubMed ID: 28017569
[TBL] [Abstract][Full Text] [Related]
34. Validation and Clinical Application of ONCOaccuPanel for Targeted Next-Generation Sequencing of Solid Tumors.
Kim M; Lee C; Hong J; Kim J; Jeong JY; Park NJ; Kim JE; Park JY
Cancer Res Treat; 2023 Apr; 55(2):429-441. PubMed ID: 36470260
[TBL] [Abstract][Full Text] [Related]
35. Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms.
Rosenthal SH; Gerasimova A; Ma C; Li HR; Grupe A; Chong H; Acab A; Smolgovsky A; Owen R; Elzinga C; Chen R; Sugganth D; Freitas T; Graham J; Champion K; Bhattacharya A; Racke F; Lacbawan F
PLoS One; 2021; 16(4):e0243683. PubMed ID: 33909614
[TBL] [Abstract][Full Text] [Related]
36. Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes.
Singh RR; Patel KP; Routbort MJ; Reddy NG; Barkoh BA; Handal B; Kanagal-Shamanna R; Greaves WO; Medeiros LJ; Aldape KD; Luthra R
J Mol Diagn; 2013 Sep; 15(5):607-22. PubMed ID: 23810757
[TBL] [Abstract][Full Text] [Related]
37. High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods.
Su D; Zhang D; Chen K; Lu J; Wu J; Cao X; Ying L; Jin Q; Ye Y; Xie Z; Xiong L; Mao W; Li F
J Exp Clin Cancer Res; 2017 Sep; 36(1):121. PubMed ID: 28882180
[TBL] [Abstract][Full Text] [Related]
38. A targeted next-generation sequencing method for identifying clinically relevant mutation profiles in lung adenocarcinoma.
Shao D; Lin Y; Liu J; Wan L; Liu Z; Cheng S; Fei L; Deng R; Wang J; Chen X; Liu L; Gu X; Liang W; He P; Wang J; Ye M; He J
Sci Rep; 2016 Mar; 6():22338. PubMed ID: 26936516
[TBL] [Abstract][Full Text] [Related]
39. Validation of a next-generation-sequencing cancer panel for use in the clinical laboratory.
Simen BB; Yin L; Goswami CP; Davis KO; Bajaj R; Gong JZ; Peiper SC; Johnson ES; Wang ZX
Arch Pathol Lab Med; 2015 Apr; 139(4):508-17. PubMed ID: 25356985
[TBL] [Abstract][Full Text] [Related]
40. Performance comparison of NextSeq and Ion Proton platforms for molecular diagnosis of clinical oncology.
Cao F; Gao L; Wei L; Chen Z; Wang Y; Ran X; Meng X; Tao J
Tumori; 2017 May; 103(3):223-230. PubMed ID: 28127742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
